Patents by Inventor Konstantin Konstantinov

Konstantin Konstantinov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6953692
    Abstract: A device and method for seed-train expansion of a source of mammalian cells and their use in production of proteins expressed by the cells comprising the use of a dedicated inoculation bioreactor for expanding the cells prior to the transfer to a production bioreactor is disclosed. The novel inoculation bioreactor is designed to facilitate an improved method of mammalian cell seed-train expansion, and is distinguished by the presence of an “inoculation well” which communicates with the interior of the bioreactor and which facilitates the growth of mammalian cells for commercial seed-train expansion. The method comprises adding the cryopreserved cells to media within the inoculation well of the inoculation bioreactor, enabling the cells to grow to a predetermined concentration within the inoculation well by monitoring and adjusting the condition of the media and environment, and thereafter incrementally increasing the volume of the media within the reactor so that optimal cell growth is maintained.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: October 11, 2005
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Rudiger Heidemann, Mokhtar Mered, James D. Michaels, Konstantin Konstantinov
  • Publication number: 20030113915
    Abstract: A device and method for seed-train expansion of a source of mammalian cells and their use in production of proteins expressed by the cells comprising the use of a dedicated inoculation bioreactor for expanding the cells prior to the transfer to a production bioreactor is disclosed.
    Type: Application
    Filed: December 18, 2001
    Publication date: June 19, 2003
    Applicant: Bayer Corporation (an Indiana Corporation)
    Inventors: Rudiger Heidemann, Mokhtar Mered, James D. Michaels, Konstantin Konstantinov
  • Patent number: 6338964
    Abstract: A cell culture medium which is low in dissolved carbon dioxide is disclosed. The medium contains less than about 1 g/L added sodium bicarbonate and includes an organic buffer and a metal complexing agent. The medium is preferably essentially free of added sodium bicarbonate. Methods of use of the medium in culturing mammalian cells, particularly cells engineered to produce recombinant factor VIII, are also disclosed.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: January 15, 2002
    Assignee: Bayer Corporation
    Inventors: Ricaredo Matanguihan, Eva Sajan, Konstantin Konstantinov, Michael Zachariou, Charles Olson